This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Agmatine Sulfate

Well Researched

Endogenous arginine metabolite with a multi-receptor footprint — modest NMDA antagonism (GluN2B-preferring), imidazoline I1/I2 + alpha-2…

Aliases (4)

Agmatine · AGM · Decarboxylated L-arginine · Agmatine sulphate

TYPICAL DOSE

500 mg

Daily

ROUTE

Oral (powder)

Oral / mixed in liquid

CYCLE

None required. Daily-safe

Continuous / daily

STORAGE

Room temp; sealed, dry

Cool, dry place

Overview

What is Agmatine Sulfate?

Agmatine is a biogenic amine derived from the decarboxylation of arginine, found endogenously and in some fermented foods. As a supplement, it is sold as agmatine sulfate and used by lifters (pump, cell volumization) and by the nootropic community (mood, neuropathic pain, NMDA modulation).

Key Benefits

Modulates neuropathic pain, supports mood and stress resilience, augments antidepressant and anxiolytic effects, and provides exercise-related vasodilation (the "pump") via nitric oxide modulation.

Mechanism of Action

NMDA receptor antagonist, alpha-2 adrenergic and imidazoline receptor agonist, and modulator of nitric oxide synthase isoforms (inhibits iNOS/nNOS, supports eNOS). Affects polyamine metabolism and opioid system tone.

Pharmacokinetics

PeakHalf-life

Approximate curve — visual aid only, not data-precise PK

▸ Mixing & scoop math Powder

Mixing

• Mix into 8-16 oz cold water (or sports drink / protein shake). Most powders dissolve in < 30 sec with a brisk stir.
• If using a shaker, add liquid first, then powder, then shake — minimizes foam and clumps.
• Hot water is fine for most amino acids and creatine; avoid for heat-sensitive compounds (NAC degrades above ~60 °C).
• Drink within 5-10 min of mixing — most powders are stable in solution but taste degrades.

Peptide Interactions

memantine:

Synergistic

Theoretical NMDA-antagonist synergy for opioid/stimulant tolerance prevention. Mechanism overlap (GluN2B preferential for both) suggests potentiation. Caveat…

magnesium (especially L-threonate):

Synergistic

Mg is the physiological NMDA gatekeeper (voltage-dependent block); agmatine adds GluN2B-preferential channel block. Excellent safety overlap. Already in the …

taurine:

Synergistic

Both are inhibitory/calming neuromodulators with no mechanistic conflict. Taurine has GABAergic and glycinergic effects; agmatine is imidazoline/NMDA. Combin…

alcar (acetyl-l-carnitine):

Synergistic

No direct interaction; complementary. ALCAR feeds mitochondrial fatty acid oxidation, agmatine modulates polyamine flux. Both planned in the canonical stack.

l-tyrosine:

Synergistic

Neutral. Tyrosine boosts dopamine/norepinephrine synthesis pre-stress; agmatine modulates downstream. Planned co-use is fine.

citrulline malate (pre-workout):

Synergistic

Synergistic for pump — citrulline raises arginine substrate, agmatine downregulates iNOS/nNOS while raising eNOS. Standard pre-workout combo.

opioids (clinically interesting):

Synergistic

Animal-strong, human-thin. Plausible: lower opioid dose for same analgesia + reduced tolerance accumulation. Off-label / not for self-treatment without presc…

Strong antihypertensives (clonidine, prazosin):

Avoid

Additive hypotension via alpha-2/imidazoline overlap. Not relevant for users in this archetype.

High-dose memantine without medical supervision:

Avoid

Compounded NMDA block — not dangerous at agmatine's modest contribution but uncharacterized. If using both, start each one alone first.

MAOIs (high-theoretical caution):

Avoid

Agmatine is itself oxidized by diamine oxidase, not classical MAO, so the interaction is theoretical rather than serotonin-syndrome-mechanistic. Still worth …

Quality Indicators

✓

Single-ingredient, COA-backed

Look for single-ingredient powders from vendors who publish a Certificate of Analysis.

✓

Mixes cleanly

Should dissolve or suspend cleanly in water without large clumps once stirred.

Off taste or smell

Strong rancid, fishy, or chemical odors can indicate oxidation or contamination.

✗

Color or texture change over time

A powder that yellows, clumps, or hardens over time may be hygroscopic and degraded.

What to Expect

First dose
For stim-class powders: acute effect within 30-60 min.
Week 1-2
For volumizers (creatine, betaine): muscle fullness builds.
Week 2-4
Performance gains plateau into a new baseline.
Ongoing
Maintenance dose continuous; cycle off only if specific indication.

Side Effects & Safety

Common (>10% users): Mild GI symptoms — loose stool, mild nausea, indigestion. More common at 2.67 g/day; rare at ≤1 g/day. Resolves on dose reduction or food co-administration.
Less common (1-10%): Headache (especially at higher doses, possibly related to NO-driven vasodilation). Mild reduction in heart rate / blood pressure (alpha-2 / imidazoline mechanism — rarely symptomatic, but stack-relevant for anyone on antihypertensives). Mild fatigue at very high doses (>3.5 g/day).
Rare-serious (<1% but worth knowing): No documented serious AEs in the published literature even at 5-year continuous use of 2.67 g/day. Theoretical risks: symptomatic hypotension if combined with other antihypertensives (clonidine, prazosin, beta-blockers); theoretical hypoglycemia (animal data shows mild fasting glucose reduction). No reported hepatotoxicity, nephrotoxicity, or QT effects.
Specific watch periods: First 1-2 weeks for GI tolerability. First month for blood pressure if hypotension-prone. No known SJS/DRESS-type risks (this is not a typical concern for agmatine).
Theoretical hormone modulation: Animal data shows agmatine ICV (intracerebroventricular, not oral) stimulates LH-releasing hormone and LH release in ovariectomized rats. Oral data in humans does not show meaningful HPG effects, but the signal is worth noting. FSH effects not characterized. For a 20-year-old male with no HPG concerns this is a non-issue at typical doses; flag if bloodwork shows unusual gonadotropin patterns.